Systemic glucose homeostasis via pancreatic beta-cell function

Systemic glucose homeostasis via pancreatic beta-cell function is a complex physiological process essential for maintaining blood glucose levels within a narrow range (NIH, 2023). Pancreatic beta-cells serve as the primary sensors of circulating glucose, responding to elevated levels by secreting insulin, which facilitates glucose uptake in peripheral tissues (StatPearls, 2023). This process involves the closure of ATP-sensitive potassium (KATP) channels, membrane depolarization, and calcium influx, leading to insulin exocytosis (PubMed, PMC2811455). In metabolic disorders like Type 2 Diabetes, this homeostatic loop is compromised by insulin resistance and progressive beta-cell failure (Nature Reviews Endocrinology, 2021). While this process is the functional objective of many anti-diabetic therapies, it represents a physiological outcome rather than a discrete molecular target such as a specific receptor or enzyme (Journal of Clinical Investigation, 2020). Pharmacological agents like sulfonylureas and GLP-1 receptor agonists are used to augment this function by targeting specific proteins within the beta-cell signaling cascade (PubMed, 2022). Monitoring this function is typically achieved through biomarkers like C-peptide and HbA1c levels in clinical settings (Mayo Clinic, 2023).

Other names

Beta-cell functionGlucose-stimulated insulin secretionGSISPancreatic insulin secretionBeta-cell glucose sensing

Drugs modulate this process by acting on specific molecular targets such as KATP channels (sulfonylureas) or GLP-1 receptors (incretin mimetics) to enhance insulin secretion (StatPearls, 2023).